Benazepril hydrochloride 5 mg / hydrochlorothiazide 6.25 mg Oral Tablet [Lotensin HCT]
RxNorm 898382
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 898382 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: benazepril hydrochloride 5 mg / hydrochlorothiazide 6.25 mg Oral Tablet [Lotensin HCT].
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBD
Semantic Branded Drug (SBD):
Benazepril hydrochloride 5 mg / hydrochlorothiazide 6.25 mg Oral Tablet [Lotensin HCT]
(Atom ID: 12359000)
TMSY
Tall Man Lettering Synonym (TMSY):
Benazepril hydrochloride 5 mg / hydroCHLOROthiazide 6.25 mg Oral Tablet [Lotensin HCT]
(Atom ID: 12429226)
SY
Synonym (SY):
BZP hydrochloride 5 mg / HCTZ 6.25 mg Oral Tablet [Lotensin HCT]
(Atom ID: 5080604)
SY
Synonym (SY):
Lotensin HCT 5/6.25 (benazepril HCl / HCTZ) Oral Tablet
(Atom ID: 3642646)
SY